|
Bravo-Perez C, Sola M, Teruel-Montoya R, Garcia-Malo MD, Ortuno FJ, Vicente V, de Arriba F, Jerez A. Minimal Residual Disease in Multiple Myeloma: Something Old, Something New. Cancers (Basel). 2021 Aug 27;13(17):4332. doi: 10.3390/cancers13174332. PubMed PMID: 34503142; PubMed Central PMCID: PMC8430644.
AÑO: 2021; IF: 6.575
|
34503142
|
Bravo-Perez C, Fernandez-Caballero M, Soler-Espejo E, Garcia-Torralba E, Sorigue M, Garcia-Malo MD, Jerez A, Vicente V, Roldan V, de Arriba F. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma. J Thromb Thrombolysis. 2021 Oct;52(3):848-853. doi: 10.1007/s11239-021-02407-5. Epub 2021 Mar 1. PubMed PMID: 33649980.
AÑO: 2021; IF: 2.2
|
|
Bravo-Perez C, Pajares I, Muina B, Escobar H, Amigo ML, Garcia-Malo MD, Garcia J, Rodriguez-Pinilla SM, Piris MA, Ortuno FJ. Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma. Ann Hematol. 2020 Feb;99(2):391-393. doi: 10.1007/s00277-019-03897-3. Epub 2019 Dec 20. No abstract available. PubMed PMID: 31858188.
AÑO: 2020; IF: 3.673
|
|
Bravo-Perez C, Pajares I, Muina B, Escobar H, Amigo ML, Garcia-Malo MD, Garcia J, Rodriguez-Pinilla SM, Piris MA, Ortuno FJ. Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma. Ann Hematol. 2019 Dec;98(12):2837-2839. doi: 10.1007/s00277-019-03829-1. Epub 2019 Nov 11. No abstract available. PubMed PMID: 31712881.
AÑO: 2019; IF: 2.904
|
|
Fernandez-Caballero M, Salmeron D, Dolores Chirlaque M, Chen-Liang TH, Hurtado AM, Garcia Malo MD, Ortuno FJ, Roldan V, Vicente V, Jerez A, De Arriba F. Increasing therapy-related myeloid neoplasms in multiple myeloma. Eur J Clin Invest. 2019 Feb;49(2):e13050. doi: 10.1111/eci.13050. Epub 2018 Dec 7. PubMed PMID: 30422316.
AÑO: 2019; IF: 3.481
|